uric acid has been researched along with Carcinoma, Small Cell Lung in 1 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crohns, M | 1 |
| Saarelainen, S | 1 |
| Kankaanranta, H | 1 |
| Moilanen, E | 1 |
| Alho, H | 1 |
| Kellokumpu-Lehtinen, P | 1 |
1 other study available for uric acid and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antioxidants; Biomarkers; Bronchoalveolar Lavage Fluid; Fem | 2009 |